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Little is known about the specific neural mechanisms through which cognitive factors 
influence craving and associated brain responses, despite the initial success of cog-
nitive therapies in treating drug addiction. In this study, we investigated how cognitive 
factors such as beliefs influence subjective craving and neural activities in nicotine- 
addicted individuals using model-based functional magnetic resonance imaging (fMRI) 
and neuropharmacology. Deprived smokers (N = 24) participated in a two-by-two bal-
anced placebo design, which crossed beliefs about nicotine (told “nicotine” vs. told “no 
nicotine”) with the nicotine content in a cigarette (nicotine vs. placebo) which participants 
smoked immediately before performing a fMRI task involving reward learning. Subjects’ 
reported craving was measured both before smoking and after the fMRI session. We 
found that first, in the presence of nicotine, smokers demonstrated significantly reduced 
craving after smoking when told “nicotine in cigarette” but showed no change in craving 
when told “no nicotine.” Second, neural activity in the insular cortex related to craving 
was only significant when smokers were told “nicotine” but not when told “no nicotine.” 
Both effects were absent in the placebo condition. Third, insula activation related to 
computational learning signals was modulated by belief about nicotine regardless of nic-
otine’s presence. These results suggest that belief about nicotine has a strong impact on 
subjective craving and insula responses related to both craving and learning in deprived 
smokers, providing insights into the complex nature of belief–drug interactions.
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inTrODUcTiOn
Craving is a core symptom of drug addiction (1–3) and has been proven to be much more difficult 
to treat than physical dependency symptoms (4). Although certain mechanisms of drug addiction 
such as the malfunctioning dopaminergic system have been relatively well characterized (5–7), it 
has become clear that complex interactions exist between drug beliefs (expectancies) and pharma-
cological effects, and that these interactions may impose a profound influence on treatment outcome 
FigUre 1 | (a) Experimental design. We used a within-subject design with two factors: belief (told “no nicotine” vs. told “nicotine”) and cigarette (placebo vs. 
nicotine). (B) An exemplar stock market used in the task. Participants make 20 sequential decisions in each market and there are 10 markets in total. (c) Time 
course of the experiment. In each visit, subjective craving was measured upon arrival, before smokers were given a cigarette with or without nicotine to smoke and 
were told that the cigarette had nicotine or had no nicotine. Immediately after smoking, participants performed a sequential choice task. Craving was measured 
again immediately after the fMRI session.
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(8, 9). Previous work has shown that drug beliefs can modify 
neural activity related to alcohol (10–12), nicotine (13–15), and 
cocaine (16, 17). In particular, our recent work (15) examined 
the impact of beliefs on nicotine-induced learning signals in 
a group of non-deprived smokers using functional magnetic 
resonance imaging (fMRI) and a reward learning task. We found 
that in non-deprived smokers, belief about nicotine’s presence 
modulated both neural learning signals in the ventral striatum as 
well as learning behavior when participants smoked a cigarette 
with nicotine (15). These results demonstrate that belief has a 
powerful effect in overriding the effects of nicotine on reward 
learning. It remained unclear, however, whether such belief–drug 
interactions could modulate other aspects of drug addiction such 
as craving. The current study uses a balanced placebo design to 
directly examine the impact of belief about drugs (i.e., nicotine) 
on subjective craving and associated patterns of neural activation 
measured by fMRI among deprived smokers.
The insular cortex is one of the key brain areas most consist-
ently implicated in drug addiction (1–3, 18–21). Insular lesions 
lead to abstinence from smoking in humans (19) and reduced 
craving and drug-seeking behavior in rats (22, 23). Activation 
of the insula has been associated with exposure to smoking 
cues (24). Different from the ventral striatum, a dopaminergic 
region responsible for reinforcement learning and motivational 
abnormalities in addiction (15, 25), the insula has been typically 
considered to encode the interoceptive effects of drug taking, 
craving, and urges (2, 26). While craving and reinforcement 
learning have mostly been considered separately in previous 
studies, converging evidence suggests that interoception has a 
substantial influence on learning and other cognitive processes 
(27–29), and that the insula is involved in a much wider range 
of cognitive functions than traditionally thought. Using learning 
and decision-making paradigms, recent studies have shown that 
anterior insula activation correlates with value prediction and 
prediction errors (30), risk and risk prediction errors (31), and 
subjective feelings during decision-making (32). Mid insula has 
been reported to integrate homeostatic with cognitive informa-
tion (33). These findings lead to the recent proposal that insula is a 
critical hub for linking bodily information with decision-making 
signals (15, 29). It is therefore important to investigate how the 
insula responses related to both craving and reinforcement learn-
ing can be modulated by beliefs in deprived smokers while under 
the influence of nicotine.
Based on previous finding of the effect of belief–drug interac-
tion on learning in non-deprived smokers, we hypothesized that 
beliefs about nicotine would also modulate nicotine-induced sub-
jective craving and insula responses in deprived smokers whose 
craving levels are elevated. To test this hypothesis, we employed 
a within-subject, balanced placebo design (Figure 1A) with two 
experimental factors: belief (told “nicotine,” told “no nicotine”) 
and cigarette (nicotine, placebo/de-nicotinized), together with 
fMRI and a reward learning task (Figures 1B,C) in 24 chronic 
smokers. Similar to our previous study (15), smokers were given 
a cigarette with nicotine or without nicotine and were told that 
the cigarette either contained nicotine or not, in four separate 
visits. In contrast to our previous study (15), smokers stayed 
abstinent from smoking starting from the midnight before the 
experiment. We measured craving using self-reports both before 
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participants smoked a cigarette and after the fMRI session. We 
examined the impact of beliefs on changes in craving (i.e., post 
vs. pre-smoking). We also measured neural activity indexed by 
blood oxygen level dependent (BOLD) when subjects performed 
a sequential financial investment task. During each trial of the 
investment task, the subject places a bet bt, observes a fractional 
change in market price change rt = (pt–pt −1)/pt −1, where pt is the 
market price at time t, and receives a gain or loss gt. This fractional 
market return rt is an important value signal known to guide 
learning and is associated with neural responses in mesolimbic 
dopaminergic regions (15). Here, we used the choice-independent 
and passive value signal rt, instead of the actual gain/loss (gt = rtbt), 
or the prediction error, as our main learning signal to avoid risk 
preference –  induced variability in smokers’ bets as a potential 
confounding. Our hypothesis yields two main predictions. First, 
based on previous findings on the effects of beliefs (15, 34, 35), 
we predicted that belief about nicotine would modulate reported 
change in craving levels induced by nicotine intake in deprived 
smokers. Second, we predicted that belief would also modulate 
neural activity changes in brain regions integrating interoceptive 
information with learning signals such as the insular cortex.
MaTerials anD MeThODs
Participants
We recruited 28 chronic smokers from the community popula-
tion in Houston, TX, USA, who were not interested in quitting 
smoking. Four smokers were excluded because they had carbon 
monoxide (CO) levels outside of acceptable range [>30 parts 
per million (ppm), based on the mean exhaled CO level of 
non-deprived heavy smokers provided by manufacturer1]. Other 
exclusion criteria include: (1) left handedness; (2) claustrophobia; 
(3) DSM-IV Axis I or II diagnosis (36), exclusive of nicotine 
dependence; (4) pregnancy; (5) contraindications to MRI: 
pacemaker, aneurysm clips, neurostimulators, cochlear implants, 
metal in eyes, steel worker, or other implants; (6) active medical or 
neurologic disorder; (7) history of drug dependence (other than 
tobacco or alcohol); (8) history of head injuries resulting in loss 
of consciousness >10 min; (9) non-smoker. Because about 80% 
of tobacco users are also alcohol users in the general population 
(37), we included smokers regardless of their history of alcohol 
use. This yielded a final sample of 24 smokers. The demographics 
and smoking history of the smokers are as follows (mean ± SD): 
age, 41 ± 10 years; education, 15 ± 2.6 years; smoking history, 
25 ± 11.5 years; daily cigarettes, 15 ± 7. Participants had normal 
or adjusted to normal vision and were informed of the study 
requirements and provided written consent prior to participa-
tion. The study was approved by the Institutional Review Board 
of Baylor College of Medicine.
experimental Procedure, stimuli, and Task
We used a within-subject, placebo-balanced design that is similar 
to the one used in our previous study (15). All smokers were 
instructed to stop smoking beginning at midnight prior to the 
1 http://www.covita.net/
experiment day. Deprivation status was confirmed by exhaled 
CO levels measured upon smokers’ arrival at the laboratory. The 
average CO level of smokers was 10.4 ± 5.7 ppm, which is sig-
nificantly lower than average CO level in non-deprived smokers 
[e.g., compared to mean = 28.5 ppm in a non-deprived smoker 
group (15)].
Each smoker came to the laboratory four times on four separate 
days and participated in one of the following conditions during 
each visit (Figure  1A): told “nicotine” and received a cigarette 
with nicotine (Quest Brand, 0.6 milligrams of nicotine), told 
“nicotine” and received a de-nicotinized cigarette (Quest Brand, 
0.06 milligrams of nicotine), told “no nicotine” and received a 
cigarette with nicotine, and told “no nicotine” and received a de-
nicotinized cigarette. The 0.06 mg Quest cigarette has very low 
nicotine content; while this is not “zero” nicotine, previous studies 
suggest that cigarettes with this level of nicotine are considered by 
smokers to be subjectively less reinforcing than normal nicotine 
content cigarettes (38, 39).
The experiment was designed to be double blind. Before 
smoking, participants were told that they would receive either 
a nicotine cigarette or a de-nicotinized cigarette and that the 
experimenter would inform them about the nicotine content. 
Participants remained blind to the actual nicotine content of the 
cigarette during the experiment, and were only debriefed after 
they completed all four sessions. Although the experimenters 
giving the cigarette to the participant developed their own beliefs 
of the nicotine content of the cigarette for some sessions, the 
double-blind protocol was not broken during data collection. 
Two other researchers who were completely blind to data collec-
tion performed data analysis.
The order of the four visits was randomly assigned to each 
subject. Upon arrival at the laboratory, participants completed 
the Shiffman-Javik Withdrawal Questionnaire (SJWQ) (40) for 
craving, the Positive and Negative Affect Schedule (PANAS) (41) 
for mood and affect, and MRI safety-related questions. All par-
ticipants then received a cigarette to smoke immediately before 
the scanning session. SJWQ and PANAS were administered again 
after the scanning session.
Participants performed a reward learning task (Figures 1B,C) 
in which they made 20 sequential investment decisions for each 
of the 10 markets, yielding 200 trials per fMRI session and a 
total of four sessions. The markets were taken from real historic 
markets (15, 42–44). Different markets were used for each visit to 
prevent memory effects. At the beginning of each fMRI session, 
participants were endowed with 100 monetary units and were 
informed that their final payment would be scaled according 
to their earning in the task. For each market, the subject used a 
two-button box to move a slide bar to make 20 sequential invest-
ment decisions bt (0~100% of current portfolio) without a time 
constraint. Seven hundred fifty milliseconds after they submitted 
their choices, the market price pt was revealed and the fractional 
market price change and participants’ portfolio were updated. 
Market information for all previous segments then remained 
on the screen. The slide bar then changed from gray to red after 
another 750  ms, and participants started to make investment 
decisions for the next market segment. Different markets were 
used for the four visits.
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Behavioral Data analysis Using a linear 
Mixed-effects Multiple regression 
Model
We used a linear mixed-effects multiple regression model (45) to 
examine the impact of the value signal rt on subjects’ next bet bt+1, 
similar to the methods described in our previous work (46). The 
value signal at time t rt, is defined as the relative change in market 
price (pt − pt − 1)/pt − 1. The regression was performed simultane-
ously across all four conditions by coding the four conditions (told 
“no nicotine” and received placebo, told “nicotine” and received 
placebo, told “no nicotine” and received nicotine, told “nicotine” 
and received nicotine) as four indicator variables (told0-nic0, 
told1-nic0, told0-nic1, told1-nic1) and by including a term in the 
regression of the form CONDITION regressor for each indicator 
and regressor (see Table S1 in Supplementary Material for a com-
plete list of regressors and fixed-effect coefficients). Specifically, if 
we let lT0,t be the indicator function for trials t where the subject 
has been told the cigarette does not contain nicotine, lT1,t be the 
indicator function for trials t where the subject has been told the 
cigarette contains nicotine, lN0,t be the indicator function for trials 
t where the subject receives a placebo cigarette, and lN1,t be the 
indicator function for trials t where the subject receives a cigarette 
with nicotine, then the model for subject j is given by:
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here Zj is the design matrix for the random effects, uj is the 
vector of random effects for subject j, bt,j the within-subject 
z-normalized (over the entire experiment for subject j) bet, 
ϵt,j~N(0,σ2)IID, uj~N(0,∑), IID, and ϵ and u are independent. 
Linear contrasts were then carried out to test the significance of 
differences between coefficients. The analyses were carried out in 
R(Team) (47) with the function lme (for the mixed regression) in 
package lmer (48) and function estimable (for the linear contrasts) 
in package gmodels (49). Statistical significance was determined 
at P < 0.05 two tailed. The first and last bet of each market was 
excluded to keep consistent with the fMRI analysis.
image acquisition and fMri Data 
Preprocessing
High-resolution T1-weighted scans (1.0 mm × 1.0 mm × 1.0 mm) 
were acquired using a Magnetization-Prepared Rapid Acquisition 
with Gradient Echo (MP-RAGE) sequence. Functional images 
were acquired using echo-planar imaging (EPI), and angled 30° 
with respect to the anterior–posterior commissural line. The 
detailed settings for the functional imaging were: repetition time 
(TR) = 2000 ms; echo time (TE) = 25 ms; flip angle = 90°; 37 slices; 
voxel size: 3.4 mm × 3.4 mm × 4.0 mm. The functional scans were 
realigned to the first volume (the mean functional image), coreg-
istered to the T1 image, normalized to a standard template (MNI, 
Montreal Neurological Institute), and spatially smoothed with an 
8 mm × 8 mm × 8 mm full-width-at-half-maximum (FWHM) 
Gaussian kernel using statistical parametric mapping (SPM8; 
Wellcome Department of Imaging Neuroscience, London, UK2).
general linear Modeling of fMri Data
The anatomical and functional imaging was conducted on a 3.0-T 
Siemens Trio scanner at Baylor College of Medicine in Houston, 
TX, USA. Event-related analyses of the fMRI data were con-
ducted using statistical parametric mapping (SPM8; Wellcome 
Department of Imaging Neuroscience, London, UK) (see text 
footnote 2). GLM was conducted for the functional scans from 
each participant to identify the relationship between task events 
and hemodynamic responses. Regressors related to visual and 
motor events were created by convolving a train of delta functions 
representing the sequence of individual events with the default 
SPM basis function, which consists of a synthetic hemodynamic 
response function composed of two gamma functions. The 
following visual and motor events were included in the GLM: 
market type screen; initial market history screen; key press; first 
market price reveal; market price reveal round 2–19; last market 
price reveal. Six parameters generated during motion correction 
were entered as covariates. rt was entered as parametric regressor 
at the onset of “market price reveal round 2–19,” Regressors were 
orthogonalized in the standard SPM8 fashion.
For craving-related activations, post-smoking craving scores 
were entered as covariates for parameter estimates of “market 
price reveal round 2–19” in a second-level factorial analysis with 
the following factors: belief (told “no nicotine” vs. told “nicotine”) 
and cigarette (placebo vs. nicotine). For activations related to both 
craving and market value rt, post-smoking craving scores were 
entered as covariates for parameter estimates of rt in a second-
level factorial analysis with the same two factors. Significant 
activations were identified at the voxel level of P < 0.05 corrected 
for family wise errors (PFWE <  0.05) for single conditions, and 
voxel level of P < 0.05 uncorrected in conjunction with a cluster 
threshold of k > 54 to correct for multiple comparison at P < 0.05 
at the cluster level for contrasts between conditions based on a 
Monte Carlo simulation (50, 51).
Independent regions of interest (ROIs) were created using the 
MarsBaR toolbox (http://marsbar.sourceforge.net/) with a sphere 
of 5-mm radius (640  mm3, 10 voxels) centered at left anterior 
insula [−38 18 −2], left mid insula [−38 2 4], left posterior insula 
[−38 −14 4], right anterior insula [36 22 4], right mid insula [40 
6 4], right posterior insula [40 −14 4], based on the search term 
“interoceptive” entered into a meta-analysis in Neurosynth3; left 
2 http://www.fil.ion.ucl.ac.uk/spm/software/spm8/
3 www.neurosynth.org
FigUre 2 | (a) Change in subjective craving measured by the Shiffman-Javik withdrawal questionnaire (SJWQ). There was a significant interaction between belief 
and nicotine (P < 0.05) and no significant main effect for belief or nicotine (Ps > 0.05). (B) Both region-of-interest (ROI, P < 0.05) and whole brain analyses (P < 0.05 
corrected) suggests that post-smoking craving significantly correlated with left mid insula activation only when smokers were told “nicotine’ and smoked nicotine, 
but not in other conditions. *P ≤ 0.05, ***P ≤ 0.005. n.s., not significant. Activation maps were displayed at P < 0.05 for visualization purpose. Error bar represents 
95% confidence interval.
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ventral striatum [−12 8 −6], right ventral striatum [12 10 −6], 
based on value-based activation from a previous study using a 
similar task (44).
resUlTs
effect of Belief on learning Behavior
There was no main effect of belief or nicotine on learning behav-
ior (see Table S1 in Supplementary Material for results based on 
learning behavior using a linear mixed-effects multiple regres-
sion model). Average reaction times (RT) of the four conditions 
(told “no nicotine” and smoked placebo, told “nicotine” and 
smoked placebo, told “no nicotine” and smoked nicotine, told 
“nicotine” and smoked nicotine) were 2.93 ± 1.10 s, 2.78 ± 0.81 s, 
2.88 ± 1.01 s, 2.92 ± 0.95 s respectively. Average task lengths of 
the four conditions (told “no nicotine” and smoked placebo, told 
“nicotine” and smoked placebo, told “no nicotine” and smoked 
nicotine, told “nicotine” and smoked nicotine) were 878 ± 219 s, 
849 ± 162 s, 868 ± 201 s, 878 ± 190 s, respectively. There was no 
main effect of belief or nicotine on RT or task length (Ps > 0.1).
impact of Belief on subjective craving
We calculated change in craving, that is, the difference between 
the two craving measurements (Δcraving = post-smoking/scan-
ning craving  –  pre-smoking/scanning craving); positive scores 
indicate increased craving and negative scores indicate decreased 
craving after the experimental manipulation. There was a signifi-
cant interaction between belief (what one was told) and nicotine 
(what one received) [Figure 2A; F(1,23) = 7.66, P < 0.05] and no 
significant main effect for belief [F(1,23) = 4.08, P > 0.05] or nicotine 
[F(1,23) = 1.14, P > 0.2]. Post hoc comparisons indicated that belief-
modulated change in craving when deprived smokers smoked 
a cigarette with nicotine [paired t-test t(23) =  3.24, P <  0.005]. 
More specifically, smokers reported a significant reduction in 
craving when they smoked a nicotine cigarette and were told 
“nicotine” [one-sample t(23) = −3.02, P < 0.01]; such decrease in 
craving was absent in the case of being told “no nicotine” and 
smoked a nicotine cigarette (P > 0.1). This effect of belief was not 
observed when participants smoked a de-nicotinized cigarette 
[t(23) = −0.52, P > 0.6].
We further examined the effect of belief on the time lag between 
the two measurements and general mood measured by PANAS to 
rule out the possibility that the effect of belief on craving was 
due to differences in the time lag between two measurements or 
changes in general mood. There was no difference in time lag 
between any conditions (Figure S1A in Supplementary Material; 
Ps > 0.1). Neither belief nor nicotine had an impact on changes in 
positive mood (Figure S1B in Supplementary Material; Ps > 0.1) 
or negative mood (Figure S1C in Supplementary Material; 
Ps > 0.05) measured by PANAS.
effect of Belief on craving-related  
neural activity
Next, we examined the effect of belief on craving-related neural 
activity (Figure  2B). Independent ROI analysis suggests that 
post-smoking SJWQ score was positively correlated with activity 
in the left mid insula (centered at [−38 2 4]) when smokers were 
told “nicotine in cigarette” and smoked a cigarette with nicotine 
FigUre 3 | (a) Region-of-interest (ROI) analysis suggests that “told nicotine” elicited greater market value r-related activations in bilateral anterior, mid, and posterior 
insula regions compared to “told no nicotine” (main effect of belief, Ps < 0.05). ROIs were selected from a meta-analysis on interoception from www.neurosynth.org. 
(B) Whole brain analysis confirmed that market value r-related insula activation was only significant when subjects were told “nicotine,” but not when they were told 
“no nicotine” (P < 0.05 corrected for family wise error). The contrast between the two maps is also significant for the insula (see Results, P < 0.05 corrected). (c) 
Both ROI and whole brain analysis show that striatum activation related to market value r did not significant differ between the “told nicotine” and “told no nicotine” 
conditions at the same threshold of (a,B). The contrast between two conditions is also non-significant for the striatum even with small volume correction. *P ≤ 0.05. 
L, left; R, right. Error bar represents 95% confidence interval.
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(Figure 2B; Pearson’s r = 0.47, P < 0.05); such significant cor-
relation was absent when smokers were told “no nicotine” and 
smoked a cigarette with nicotine (Figure 2B; Pearson’s r = −0.22, 
P > 0.1) and when smokers had a placebo cigarette (Ps > 0.1). The 
differences between the correlation coefficients of craving-insula 
activation of told “nicotine” and smoked nicotine and all other 
conditions were also significant (Ps < 0.05). Whole brain analysis 
also confirmed that the difference between craving-related left 
mid insula activations in the told “no nicotine” and smoked 
nicotine, and told “nicotine” and smoked nicotine conditions was 
significant (Figure 2B lower right; P < 0.05 corrected). This result 
suggests that belief about nicotine modulated craving-related 
insula activity when nicotine was present. In the absence of nico-
tine, however, such modulation effect of belief was not observed.
effect of Belief on neural activity related 
to the Value signal rt
Next, we examined the effects of belief states on neural activity 
related to the value signal rt (see Table S1 in Supplementary 
Material for effect of belief on learning behavior). Independent 
ROI analysis suggests that for all insula ROIs (bilateral anterior, 
mid, and posterior insula), there was a significant main effect of 
FigUre 4 | smokers showed significant ventral anterior insula activation related to both market value r and post-smoking craving only when they 
were told “nicotine in cigarette” and smoked nicotine but not in other conditions. Activation maps were displayed at P < 0.05 for visualization purpose.
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belief [Figure 3A; F(1,23) > 4.4, Ps < 0.05]; there was no significant 
main effect of nicotine or belief–nicotine interaction (Fs <  3, 
Ps  >  0.1). Whole brain analysis on rt-related activation also 
confirmed that bilateral insula regions were only activated when 
participants were told “nicotine in cigarette” but not when they 
were told “no nicotine” (Figure 3B; PFWE < 0.05).
For the striatum ROIs, there was no significant main effect 
of belief or nicotine, or their interaction (Figure  3C; Fs <  4, 
Ps > 0.05). Whole brain analysis suggests that rt-related striatum 
activation was equivalent for both the told “nicotine” and told “no 
nicotine” conditions (Figure  3C; PFWE <  0.05). Taken together, 
these results suggest that value signals encoded in the insular 
cortex, but not in the ventral striatum, were modulated by belief 
about nicotine.
effect of Belief on neural activity related 
to Both craving and learning signals
Lastly, we examined the effect of belief on brain regions that might 
encode both craving and reinforcement learning by correlating 
value-related activations with post-smoking craving at the group 
level. When smokers were “told nicotine” and smoked nicotine, 
there was significant ventral anterior insular activation that 
correlated to both craving and learning signals (Figure 4, lower 
right panel; P < 0.05 corrected); such activation was attenuated 
when smokers were told “no nicotine” (Figure 4, upper and lower 
left panels; P < 0.05 corrected). These results suggest that (1) the 
left ventral anterior insula integrates both subjective craving and 
decision-making signals and (2) such activity is dependent on 
belief about nicotine rather than nicotine in deprived smokers.
DiscUssiOn
Our findings in deprived smokers are threefold. First, smoking a 
nicotine cigarette reduced craving only when subjects were told 
“nicotine in cigarette” but not otherwise. Second, craving-related 
insula activity was also modulated by belief about nicotine when 
subjects smoked a nicotine cigarette. Third, beliefs modulated 
insula activations related to computational learning signals (mar-
ket value r) regardless of the presence of nicotine. These results 
provide further evidence top-down beliefs, in deprived smokers, 
can influence a powerful neuroactive substance like nicotine at 
both behavioral and neural levels.
Previous work has addressed addiction as a problem of 
aberrant dopamine function within the framework of reinforce-
ment learning (5, 25, 52, 53). Nicotine, a nicotinic acetylcholine 
receptor agonist, is known to modulate dopamine neurotrans-
mission (54, 55), which encodes reinforcement learning signals, 
such as reward and reward prediction errors (52, 56, 57). It is 
therefore not surprising that addicted individuals show aberrant 
dopamine-dependent reward processing (5, 43). Our previ-
ous work also shows that belief about the nicotine content in a 
cigarette modulates value and reward prediction error signals at 
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both neural and behavioral levels in non-deprived smokers (15). 
Specifically, these results demonstrate that belief (expectancy) has 
a powerful effect in overriding the effects of nicotine on learn-
ing behavior and related neural activities in the striatum. These 
findings have far-reaching implications because (1) aberrant 
learning and decision making related to drug intake have been 
considered a hallmark of drug addiction and need to be “fixed”, 
and (2) learning is crucial for many aspects of cognition and leads 
to behavioral changes (53, 58, 59). Thus, by changing learning, we 
could potentially influence many important aspects of behavior 
and cognition.
One important question that remained unanswered was 
whether belief could also modulate drug-induced subjective 
states such as craving and associated patterns of brain activation. 
Craving is a core symptom of drug addiction. Its heterogeneity 
is caused by not only the substance or the belief but also differ-
ent psychological effects like anxiety, depression or compulsive 
behavior (60). Here, we address this question and extend our 
previous finding by showing that belief has a significant impact 
on subjective craving and insula activity related to both craving 
and learning when participants smoked a cigarette with nicotine. 
We also show that the effect of belief on craving is not attributable 
to general changes in positive or negative mood. These results 
suggest that craving, a core symptom and an important “feeling” 
component of addiction, can also be modulated by top-down 
beliefs. This finding provides evidence supporting cognitive 
therapies targeting maladaptive beliefs in addiction (61) and cog-
nitive strategies such as cognitive reappraisal and mindfulness, 
which attempt to attenuate craving by reinterpreting the craving 
signal (3, 62, 63). Moreover, the current study shows that neither 
belief nor nicotine alone reduces craving in deprived smokers, 
and that reduced craving was only observed when smokers were 
both told (cognitive belief) nicotine was present and nicotine 
was actually administered. This result offers a potential explana-
tion for the unsatisfying outcome of pharmacological treatment 
(e.g., nicotine replacement therapy) and cognitive therapy when 
administered alone (4, 64, 65).
Several previous laboratory studies have also demonstrated 
the impact of cognitive factors on craving and related neural 
activities. Brody et al. reported increased anterior and posterior 
cingulate activations, and decreased activities in the cuneus, lat-
eral occipital gyrus, and postcentral gyrus, when smokers actively 
tried to resist craving (1). Kober and colleagues asked smokers 
to think about short-term (pleasant) or long-term (harmful) 
consequences of smoking; such cognitive strategies significantly 
reduced craving (62), and increased neural activities in dorso-
medial, dorsolateral, and ventrolateral prefrontal cortices, and 
decreased neural activities in ventral striatum, subgenual cingu-
late, amygdala, and ventral tegmental area (66). Using positron 
emission tomography (PET), Volkow and colleagues reported 
that cognitive strategy also inhibited craving and decreased brain 
metabolism in nucleus accumbens and orbitofrontal cortex in 
cocaine addicts (3). Moreover, Tang and colleagues showed that 
2  weeks of mindfulness training produced a significant reduc-
tion in craving, accompanied by increased resting-state activity 
in anterior cingulate and prefrontal cortex in smokers (63). In 
contrast, our experimental manipulation only involved a simple 
suggestion of “nicotine in cigarette” or “no nicotine in cigarette,” 
rather than explicitly asking the participants to reduce craving 
using effortful control. This implies that belief could potentially 
be modified in a faster and easier fashion. Together with previous 
findings, the current results further demonstrate the influence of 
drug expectancies and beliefs in overriding the effect of nicotine 
on brain, behavior, and subjective states such as craving.
We also found that belief modulated activity in the insula 
related to both craving and learning signals when deprived smok-
ers performed a sequential decision-making task. The insula is 
traditionally considered to process interoceptive information 
(67, 68), which provides the basis of emotional feelings (69–71). 
Heightened awareness and attention paid to bodily signals are 
also associated with increased insula activation (69, 72). Recently, 
an increasing number of studies have suggested that the insula 
is also a key neural region involved in complex cognition and 
decision making (26, 32, 44, 46, 72, 73), possibly by providing 
information of an agent’s internal states to exteroceptive decision-
making processes (29). At the neuroanatomical level, the insula 
is known to contain high density of both nicotinic cholinergic 
receptors (74) as well as dopamine D1 receptors (75). The insula 
also receives strong dopaminergic innervations (76), and the 
disruption of these innervations directly disrupts aversive learn-
ing (77). It is therefore not surprising that malfunctioning of the 
insula has been associated with pathological decision making (2, 
78) as well as subjective craving in addiction (1, 3). Attenuated 
insular cerebral blood flow has been observed in alcoholic sub-
jects (79). In addition, insula–amygdala functional connectivity 
is elevated during nicotine withdrawal in cigarette smokers; 
such hyper-connectivity could be down regulated by varenicline 
and nicotine, two nicotinic acetylcholine receptor agonists and 
cessation aids for nicotine addiction (80). Damage to the insula 
disrupts craving and interoceptive representation of drugs in 
addiction (19, 81).
It is worth noting that belief selectively modulated subjective 
craving and insula activation, but not learning-related behav-
ior (Table S1 in Supplementary Material) or striatum activity 
(Figure 3C) in deprived smokers. This is in sharp contrast to 
our previous finding of the impact of belief on striatal signals 
and choice behavior in non-deprived smokers (15). This finding 
suggests that what belief really had an impact on, and what the 
insula encoded essentially, was interoceptive information (i.e., 
craving) during decision making in deprived smokers, despite 
of the fact that insula activation covaried with both craving and 
learning signals when subjects were told “nicotine in cigarette” 
and smoked a nicotine cigarette (and not otherwise). Together 
with our previous finding in non-deprived smokers, these 
results also indicate that interoceptive states (i.e., deprived vs. 
non-deprived) could greatly shift the influence of beliefs to 
difference aspects of addiction (i.e., craving vs. reinforcement 
learning). We speculate that the insula could be a neural substrate 
integrating interoceptive and reinforcement learning aspects of 
addiction (25, 82) through: (1) the initial interoceptive state 
of the agent (“interoceptive representation”); (2) interoceptive 
value associated with drugs or drug cues (“interoceptive valu-
ation”), (3) interoceptive consequences following choosing a 
drug/drug-cue vs. a non-drug stimulus (“interoceptive outcome 
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evaluation”), and (4) updating the previous interoceptive state 
and valuation based on the interoceptive outcomes (“interocep-
tive learning”).
In summary, we show that in deprived smokers, belief about 
nicotine modulates subjective craving and activity in neural 
structures that process interoceptive information such as the 
insular cortex. These results provide compelling evidence sup-
porting a strong influence of beliefs to counter drug effects on 
craving and addiction, as well as insights into the mechanisms of 
cognitive treatments for addiction.
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